← Evidence map

ReviewMolecular cancer2026

SOS1: tracking the evolving path from promising to actionable therapeutic target in RAS-dependent cancers.

Luis Luna-Ramírez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026

this papercites it

SOS1: tracking the evolving path from promising to actionable therapeutic target in RAS-dependent cancers. | OpenQuestion